Ziopharm Oncology reported $-8264000 in Operating Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Amgen AMGN:US USD 2.74B 562M
AstraZeneca AZN:LN USD 1.25B 706M
Baxter International BAX:US USD -2799000000 3.15B
Biogen BIIB:US USD 1.32B 1.37B
Bristol Myers Squibb BMY:US USD 2.47B 117M
Corcept Therapeutics CORT:US USD 31.93M 502K
Curis CRIS:US USD -12606000 2.46M
Gilead Sciences GILD:US USD 2.84B 808M
GlaxoSmithKline GSK:LN GBP 1.19B 110M
Immunogen IMGN:US USD -77429000 16.38M
Intercept Pharmaceuticals ICPT:US USD -101903000 88.54M
Intrexon XON:US USD -7614000 16.55M
IONIS PHARMACEUT IONS:US USD -59154000 26.36M
Johnson & Johnson JNJ:US USD 5.82B 18M
Karyopharm Therapeutics KPTI:US USD -30839000 12.07M
Merk MRK:US USD 3.99B 939M
Novartis NOVN:VX USD 2.17B 60M
Pfizer PFE:US USD 9.41B 2.69B
Ptc Therapeutics PTCT:US USD -68187000 24.17M
Regeneron Pharmaceuticals REGN:US USD 1.22B 113.8M
Sangamo Biosciences SGMO:US USD -54894000 9.16M
Tg Therapeutics TGTX:US USD -34963000 3.98M
Verastem VSTM:US USD -17709000 3.69M
YTE INCY:US USD 138.38M 116.06M
Ziopharm Oncology ZIOP:US USD -8264000 969K